Literature DB >> 6581382

Large-scale purification of murine I-Ak and I-Ek antigens and characterization of the purified proteins.

A P Turkewitz, C P Sullivan, M F Mescher.   

Abstract

Detailed analysis of the role of the structural characteristics of these molecules will require isolation of relatively large amounts of these antigens in serologically active form. We have purified murine Ia antigens on a large scale by affinity chromatography using monoclonal antibodies coupled to Sepharose 4B. Both I-Ak and I-Ek were isolated by sequential passage of cell lysate over columns prepared using specific monoclonal antibodies. Elution of the bound antigens required high pH (11-12) but, nonetheless, the purified material was 50-75% serologically active. Using LPS-stimulated spleen cells or B-lymphocyte tumor cells as starting material, 0.5 mg of each antigen can be readily purified. Based on antigen yields, it can be estimated that normal B-cells have about the same surface density of Class I and Class II MHC antigens. LPS blasts, in contrast, have normal levels of Class I antigen but 3-5 times higher levels of Class II antigens. We have now purified I-Ak and I-Ek from a number of different cell sources and have noted differences in both the mol. wts of the alpha- and beta-chains and in their apparent associations with cytoskeletal components. Proteins having the same apparent mol. wts as actin and myosin co-purify with both I-Ak and I-Ek antigens from various sources. These proteins do not co-purify with H-2K and D molecules obtained by similar methods, suggesting that Ia antigens may specifically interact with cytoskeletal elements.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6581382     DOI: 10.1016/0161-5890(83)90137-2

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  8 in total

1.  Monoclonal antibodies to sheep lymphocytes. I. Identification of MHC class II molecules on lymphoid tissue and changes in the level of class II expression on lymph-borne cells following antigen stimulation in vivo.

Authors:  J Hopkins; B M Dutia; I McConnell
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

2.  Antigenic competition at the level of peptide-Ia binding.

Authors:  B P Babbitt; G Matsueda; E Haber; E R Unanue; P M Allen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Antigen presentation by supported planar membranes containing affinity-purified I-Ad.

Authors:  T H Watts; A A Brian; J W Kappler; P Marrack; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

4.  Identification of a peptide binding protein that plays a role in antigen presentation.

Authors:  E K Lakey; E Margoliash; S K Pierce
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

5.  A lipopolysaccharide-induced DNA-binding protein for a class II gene in B cells is distinct from NF-kappa B.

Authors:  E M Gravallese; M R Boothby; C M Smas; L H Glimcher
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

6.  Isolation of a functional antigen-Ia complex.

Authors:  M Srinivasan; S K Pierce
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

7.  Antigen presentation by liposomes bearing class II MHC and membrane IL-1.

Authors:  O Bakouche; L B Lachman
Journal:  Yale J Biol Med       Date:  1990 Mar-Apr

8.  Antibody recognition of an immunogenic influenza hemagglutinin-human leukocyte antigen class II complex.

Authors:  N R Nygard; C Bono; L R Brown; J Gorka; K S Giacoletto; W T Schaiff; M B Graham; D W McCourt; M Kabeer; V L Braciale
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.